Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1800.46%
operating margin TTM
-1971.46%
revenue TTM
37.25 Million
revenue per share TTM
0.21$
valuation ratios | |
|---|---|
| pe ratio | -7.78 |
| peg ratio | -1.05 |
| price to book ratio | 3.79 |
| price to sales ratio | 145.95 |
| enterprise value multiple | -7.89 |
| price fair value | 3.79 |
profitability ratios | |
|---|---|
| gross profit margin | 91.23% |
| operating profit margin | -1971.46% |
| pretax profit margin | -1800.46% |
| net profit margin | -1800.46% |
| return on assets | -44.5% |
| return on equity | -43.17% |
| return on capital employed | -50.82% |
liquidity ratios | |
|---|---|
| current ratio | 22.61 |
| quick ratio | 22.61 |
| cash ratio | 3.28 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 2,087.84 |
| cash conversion cycle | -2,087.84 |
| receivables turnover | 0.00 |
| payables turnover | 0.17 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.05 |
| debt equity ratio | 0.06 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.05 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -7.25 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.37 |
| cash per share | 3.23 |
| operating cash flow per share | -1.37 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -7.25 |
| short term coverage ratios | -62.54 |
| capital expenditure coverage ratio | -574.28 |
Frequently Asked Questions
When was the last time Relay Therapeutics, Inc. (NASDAQ:RLAY) reported earnings?
Relay Therapeutics, Inc. (RLAY) published its most recent earnings results on 06-11-2025.
What is Relay Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Relay Therapeutics, Inc. (NASDAQ:RLAY)'s trailing twelve months ROE is -43.17%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Relay Therapeutics, Inc. (RLAY) currently has a ROA of -44.5%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did RLAY's net profit margin stand at?
RLAY reported a profit margin of -1800.46% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is RLAY's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 22.61 in the most recent quarter. The quick ratio stood at 22.61, with a Debt/Eq ratio of 0.06.